Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2008
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435726 Thalidomide and a topoisomerase inhibitor anticancer drug such as irinotecan; reduces toxicity related side effects of anticancer drug
10/14/2008US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury
10/14/2008US7435583 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells
10/14/2008US7435417 Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2318128C Oral liquid compositions
10/14/2008CA2288821C Modulation of human mast cell activation
10/14/2008CA2238937C Delivery system for localized administration of medicaments to the upper respiratory tract
10/09/2008WO2008121467A2 Combination therapy for treating cancer
10/09/2008WO2008120815A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008WO2008120813A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
10/09/2008WO2008120736A1 Transpulmonary liposome for controlling drug arrival
10/09/2008WO2008120720A1 Dentinogenesis promoter and dentinogenic pulp-capping material
10/09/2008WO2008120684A1 Method for determining prognosis of acute central nervous system disorder
10/09/2008WO2008120219A2 Compositions and methods for cell killing
10/09/2008WO2008119988A1 New combination for use in the treatment of inflammatory disorders
10/09/2008WO2008119500A1 Methods for treating neovascular ocular diseases
10/09/2008WO2008119170A1 Method of determining risk of scoliosis
10/09/2008WO2008119163A1 Multi-nutrient milk fortifier
10/09/2008WO2008103301A3 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology
10/09/2008WO2008098871A3 Use of chitosans for the treatment of nail inflammatory diseases
10/09/2008WO2008098869A3 Use of chitosans to increase nail growth rate
10/09/2008WO2008071790A3 Novel compositions and uses thereof
10/09/2008WO2008021729A3 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
10/09/2008WO2008021728A3 Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents
10/09/2008WO2007103009A3 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008US20080249029 Administering (S)-N-Methyl-D-phenylalanyl-N-[4-[(aminoiminomethyl)aminol-1-(2-benzothiazolylcarbonyl)butyl-L-prolinamide as a protease activated receptor-2 modulator
10/09/2008US20080249025 Peptide fragments of p21; antiproliferative agents
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080248571 Method of Production of Artificial Skin
10/09/2008US20080248566 Matriptase, a serine protease and its applications
10/09/2008US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity
10/09/2008US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1
10/09/2008US20080248133 Compositions and methods for nutrition supplementation
10/09/2008US20080248132 Compositions and methods for nutrition supplementation
10/09/2008US20080248095 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment
10/09/2008US20080248070 pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent
10/09/2008US20080248049 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy
10/09/2008US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders
10/09/2008US20080248036 Treatment with anti-vegf antibodies
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/09/2008US20080247965 Metering valve and pressurized solution aerosol comprising bronchodilator, hydrofluorocarbon propellant, and cosolvent within container having inorganic coating
10/09/2008US20080247962 Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008US20080247625 Method and System for Leading Macromolecule Substances into Living Target Cells
10/09/2008DE102007017433A1 Identifying substances suitable for treating a glucose metabolism disorder comprises determining if a test substance inhibits the activity or expression of FYVE finger-containing phosphatidylinositol kinase
10/09/2008CA2682930A1 New compositions and methods for cell killing
10/09/2008CA2682736A1 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
10/09/2008CA2682572A1 New combination for use in the treatment of inflammatory disorders
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682376A1 Transpulmonary liposome for controlling drug arrival
10/09/2008CA2682114A1 Method of determining risk of scoliosis
10/09/2008CA2681361A1 Methods for treating neovascular ocular diseases
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978108A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977773A1 Ameliorating agent for aluminum storage disease
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977753A1 Combined preparation comprising anthracycline derivatives
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1977741A2 Use of renin inhibitors in therapy
10/08/2008EP1976977A2 Placental stem cell populations
10/08/2008EP1976524A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts
10/08/2008EP1976520A2 Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy
10/08/2008EP1976499A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases
10/08/2008EP1976495A2 Compounds acting on the serotonin transporter
10/08/2008EP1790357B1 Perorally administrable antimicrobial composition
10/08/2008EP1732567B1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
10/08/2008EP1689411B1 Graduated estrogen contraceptive
10/08/2008EP1596841B1 Therapeutic system comprising amoxicillin and clavulanic acid
10/08/2008EP1583522B1 Use of cyclin d1 inhibitors for breast cancer treatment
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1499360B1 Formulation comprising buprenorphine
10/08/2008EP1476128B1 Lipase inhibiting composition
10/08/2008EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc
10/08/2008EP1357811B1 Composition and method for smoke detoxification
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1296633B1 Medicinal product package for eradication therapy
10/08/2008EP1199565B1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1163364B1 Screening method involving mgdg synthase
10/08/2008EP1044015B1 Formulations for amylin agonist peptides with insulin
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282743A Bacteriocin and novel bacterium mycopremna
10/08/2008CN101282732A Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material
10/08/2008CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/08/2008CN101278933A Medicament composition containing dimemorfan and method of preparing the same
10/08/2008CN101278905A Ophthalmic composition containing natamycin, use and preparation method thereof
10/08/2008CN101278872A Nano memory alloy intrauterine device
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100423790C PPMA(polymethyl methacrylate) bone cement containing antibiotic
1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 1151